1

PETER ERLINDER – The truth behind the high cost of hepatitis C

Last week’s commentary “Who gets hepatitis C drugs? Who pays?” (Aug. 10) by North Memorial Health Care CEO Kevin Croston and Medica vice president Robert Longendyke responded to a first-in-the-nation class-action lawsuit seeking the new U.S. Food and Drug Administration (FDA) “breakthrough” cure for life-threatening hepatitis C infections. Brought by 1,500 Minnesota Department of Corrections prisoners, the lawsuit was first …